New appointment at MDS Pharma Services
This article was originally published in Scrip
MDS Pharma Services (US) has appointed Dr Ross Tonkens as vice-president of medical affairs, to provide medical oversight for the company's Phase IIa clinical research activities and to direct the medical and clinical activities of its development and regulatory services business. Dr Tonkens will design clinical study protocols, provide medical consultation to clients and chair the company's development and regulatory services medical advisory board. In addition, he will represent MDS Pharma Services and serve as the 2008 chair of the ethics and clinical practice committee of the Association of Clinical Research Organizations (ACRO). Before joining MDS, Dr Tonkens was chief medical officer of the Duke University biotechnology spin-off Regado Biosciences, and was global head of cardiovascular therapeutics at Quintiles.